Nuplazid and Clozaril Are Most Reliable Parkinson’s Psychosis Therapies, Review Finds


(March 8, 2018) - The antipsychotics Nuplazid (pimavanserin) and Clozaril (clozapine) are the only therapies shown to improve Parkinson’s disease psychosis (PDP) symptoms without impairing motor function, in double-blind, placebo-controlled clinical trials, according to a review in the journal Expert Opinion on Pharmacotherapy. Read more

Click for a printer friendly version

Back to top